Jul 09,2020

Self-Administered Skills-Based Virtual Reality Intervention for Chronic Pain: Randomized Controlled Pilot Study

Patients with chronic pain often have limited access to comprehensive care that includes behavioral pain management strategies. Virtual reality (VR) is an immersive technology and emerging digital behavioral pain therapy with analgesic efficacy for acute pain. We found no scientific literature on skills-based VR behavioral programs for chronic pain populations.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Nov 19,2020

Asthma Patients Maintain High Medication Adherence When Using Propeller Health to Manage Their Condition

Patients using Propeller Health to manage their asthma experienced a significant decline in rescue inhaler use and higher medication adherence rates compared to patients not using the platform, according to a new randomized controlled trial published in The Journal of Allergy and Clinical Immunology: In Practice by researchers from Propeller and NorthShore University HealthSystem.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 26,2021

Adherence to asthma and COPD medication differs significantly by age

Adherence to asthma and COPD medication differs significantly by age, diagnosis and other demographics, suggesting an opportunity to tailor adherence education to each patient, according to new research from Propeller Health. According to the study of 8,385 patients, adolescents and adults less than 40 years of age with asthma were less adherent to their controller medication and had less well-controlled disease than other age groups. Adults over 60 and children with asthma were the most adherent and the most well-controlled, while medication adherence was lowest in young adults aged 18-29 at 39.5%.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 24,2021

AppliedVR Completes Pivotal Trial Finding Virtual Reality Is a Holistic Treatment for Chronic Pain

AppliedVR, a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), evaluating virtual reality (VR) therapy for treating chronic pain at home. The study, which was published in Journal of Medical Internet Research (JMIR), found that AppliedVR’s EaseVRx device produced “clinically meaningful” improvement in multiple pain outcomes, and had high participant satisfaction and engagement.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Oct 18,2021

Propeller Health research shows digital health programs help improve outcomes for vulnerable and underserved populations with chronic respiratory conditions

Propeller Health, a leader in digital health and therapeutics for asthma and chronic obstructive pulmonary disease (COPD), revealed two recent studies that showed that digital health interventions alongside appropriate care resources and tools can expand access and improve outcomes for elderly and underserved populations. Propeller’s digital health platform includes Bluetooth® connected inhaler sensors that chime medication reminders and record inhaler medication use, paired with a smartphone app that provides education and feedback to support self-management.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 21,2022

AppliedVR Announces Results from a Clinical Trial Follow-up Study Finding RelieVRx Delivers Durable Effects Six Months After Completing Treatment

AppliedVR, an immersive therapeutics pioneer advancing a novel approach to medicine, today announced the results from a follow-up study that analyzed the durable effects of its flagship product, RelieVRx, which was recently granted marketing authorization by the FDA for chronic low back pain (CLBP). The research was published in the Journal of Medical Internet Research (JMIR) and reported the six-month follow-up results from a previous randomized controlled trial (RCT) of RelieVRx (formerly named EaseVRx). Researchers sought to evaluate the lasting effects of the RelieVRx eight-week, self-administered behavioral skills-based VR program versus sham VR in 188 adults with CLBP.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Jan 05,2023

Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes

Akili, Inc. today announced topline results of the STARS-ADHD-Adolescents label expansion study evaluating the efficacy and safety of EndeavorRxⓇ (AKL-T01) in adolescents ages 13-17 with attention-deficit/hyperactivity disorder (ADHD). The pivotal study achieved its predefined primary efficacy outcome, showing statistically significant improvement in attentional functioning after four weeks of treatment. Consistent improvements were also seen in a range of secondary measures of ADHD-related inattention symptoms and functioning.

CLINICAL STUDY

#pdt

#software

View Analyst & Ambassador Comments
Go to original news
Jan 09,2023

Dario Publishes New Research in Peer Reviewed Journal Demonstrating Improved Outcomes by Race and Ethnicity

DarioHealth Corp., announced today the publication of new research in the peer-reviewed journal Applied Sciences demonstrating improved outcomes for users living with diabetes across different racial and ethnic groups. The research appears in the journal as part of the Special Issue: Digital Therapeutics Applications for Chronic Disease Management. The results showed no statistical difference in the levels of engagement across racial and ethnic groups, and significant improvements in average blood glucose between the first and last month with no statistical difference between racial and ethnic groups.

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Jan 25,2023

Study: New VR sensory room reduces anxiety in people with intellectual disability

A new VR programme with interactive sight, sound, and touch experiences has helped improve outcomes for adults with neurodevelopmental disabilities, including autism and intellectual disability. The five-month preliminary study evaluated the viability and benefits of using Devika's Evenness VR Sensory Space technology as an intervention tool among 31 adults with different neurodevelopmental disabilities and their carers. Based on pre and post-scores of the users, the technology helped reduce their anxiety, and in particular, lowered depressive symptoms among participants with depression.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Jan 31,2023

MedRhythms' Feasibility Study Shows Positive Topline Results in Parkinson's Disease

MedRhythms announced the successful completion of a multi-site feasibility study of MR-005, its investigational asset in development for the treatment of gait deficits in Parkinson's disease (PD). The MR-005 feasibility study results revealed enhanced quality of life and high patient adherence rates, which were the primary endpoints for this study. Additionally, preliminary results showed improvement in motor symptoms of PD, walking capacity and functional mobility. The results of this study will be submitted for a peer-reviewed publication and also presented at the upcoming American Physical Therapy Association Combined Sections Meeting.

CLINICAL STUDY

#software

#connected device

View Analyst & Ambassador Comments
Go to original news
Subscribe to CLINICAL STUDY